FDA anticipates 'short-term' EpiPen shortage

The US Food and Drug Administration added EpiPen 0.3 mg and EpiPen Jr 0.15 mg Auto-Injectors as well as generic versions of these products to its drug shortages list Wednesday. The agency's website cites "manufacturing delays" as the "shortage reason" but notes that these products are still currently available.

New Alternatives to Epipen

 The cost of EpiPen has shot up over 500-percent over the past ten years.  But there are other, lower-cost options for people who need those injections to stay alive in an emergency.